Letter in response to David N. Louis et al, international society of neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading, Brain pathology, doi: 10.1111/bpa.12171

Brain Pathology

Volumn 24, Issue 6, 2014, Pages 671-672

  Hainfellner, Johannes ^a   Louis, David N ^b   Perry, Arie ^b   Wesseling, Pieter ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CONSENSUS DEVELOPMENT; LETTER; MEDICAL SOCIETY; NERVOUS SYSTEM TUMOR; NEUROPATHOLOGY; PRACTICE GUIDELINE; TUMOR CLASSIFICATION; CLASSIFICATION; HUMAN; NERVOUS SYSTEM NEOPLASMS;

HUMANS; NERVOUS SYSTEM NEOPLASMS;

EID: 84912034451     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12187     Document Type: Letter

References (2)

1. Berghoff AS, Stefanits H, Woehrer A, Heinzl H, Preusser M, Hainfellner JA, (2013) Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers. Clin Neuropathol 32: 148-158.
2. Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, et al (2011) NCCN task force report: evaluating the clinical utility of tumor markers in oncology. J Natl Compr Canc Netw 9 (Suppl. 5): S1-S32.